Home › Chronic Inflammatory Demyelinating Polyradiculoneuropathy › Missouri › St. Louis
Chronic Inflammatory Demyelinating Polyradiculoneuropathy clinical trials in St. Louis, MO
5 studies for Chronic Inflammatory Demyelinating Polyradiculoneuropathy are looking for participants at sites in and around St. Louis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
RecruitingPhase 3
- Washington University School of Medicine - Siteman Cancer Center- Site Number : 8400037, St Louis
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
RecruitingPhase 3
- Clinical Study Site, Edwardsville · 18 mi away
A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
RecruitingPhase 2
- The Washington University, St Louis
A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
RecruitingPhase 3
- The Washington University, St Louis
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
RecruitingObservational study
- HSHS St. Elizabeths Hospital, O'Fallon · 16 mi away
Chronic Inflammatory Demyelinating Polyradiculoneuropathy trials in other cities
- New York City, NY7 studies
- Miami, FL6 studies
- Houston, TX6 studies
- Kansas City, KS5 studies
- Indio, CA5 studies
- Philadelphia, PA5 studies
- New Haven, CT5 studies
- Tampa, FL4 studies
- Milwaukee, WI4 studies
- Cleveland, OH4 studies
- Birmingham, AL4 studies
- Washington, DC4 studies
Other studies in St. Louis
- Non-Small Cell Lung Cancer73 studies
- Breast Cancer64 studies
- Metastatic Cancer54 studies
- Colorectal Cancer50 studies
- Prostate Cancer46 studies
- Cancer (all types)46 studies
- Lung Cancer39 studies
- Ovarian Cancer38 studies
- Pancreatic Cancer33 studies
- Endometrial Cancer29 studies
- Head and Neck Squamous Cell Carcinoma28 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.